On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
AI has been touted as a tool to streamline drug R&D, which can cost $2.6 billion and take up to 15 years, according to the Journal of Medicinal Chemistry. But whether AI will actually develop better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results